Management of prostate/ bladder cancer; basic/translational research into molecular mechanisms of progression; cancer-induced bone disease; biomarker research
Management of urological malignancies, in particular prostate and bladder cancer. Phase III clinical trials, Chief Investigator, HTA NIHR ProtecT (Prostate testing for cancer and Treatment) study; translational biomarker research; PI NCRI ProMPT (Prostate Mechanisms of Progression and Treatment) study; basic science research including molecular and epigenetic mechanisms of disease progression in prostate/bladder cancer.
Freddie Hamdy joined Oxford in October 2008 as Head of the Nuffield Department of Surgery, Nuffield Professor of Surgery, Professor of Urology and Honorary Consultant Urological Surgeon at the Oxford Radcliffe Hospitals as well as Fellow of Balliol College. He has spent the past 10 years as founding Chair of Urology and was Director of the Division of Clinical Sciences, then Head of Oncology at the University of Sheffield. He trained in Surgery and Urology at Liverpool, Sheffield and Newcastle. His research activities encompass clinical, translational and basic science programmes on the biology of prostate and bladder cancer. He is Chief Investigator of many studies including the ProtecT (Prostate testing for cancer and Treatment) study of case-finding and randomised controlled trial of treatment effectiveness in prostate cancer - the largest of its kind worldwide. He was the first recipient of the Crystal Matula award from the European Association of Urology in 1996, and the Golden Telescope award from the British Association of Urological Surgeons in 2002. He has been Chairman of the Scientific Committee at the European Association of Urology since 2004, is a Board member of the French National Cancer Institute (INCa), and was elected Fellow of the Academy of Medical Sciences in 2007. He has authored over 200 peer-reviewed articles, and raised to date over £40m in peer-reviewed grants. He is establishing various multidisciplinary research platforms at Oxford and introducing with colleagues a new centre for evaluation of minimally invasive technology including robotic surgery. He received a NIHR Senior Investigator award in 2010.